| 國立成功大學 |
2023 |
Recommendations and guidelines for the diagnosis and management of Coronavirus Disease-19 (COVID-19) associated bacterial and fungal infections in Taiwan
|
Wu, H.-Y.;Chang, P.-H.;Huang, Y.-S.;Tsai, C.-S.;Chen, K.-Y.;Lin, I.-F.;Hsih, W.-H.;Tsai, W.-L.;Chen, J.-A.;Yang, T.-L.;Lee, C.-Y.;Ho, T.-S.;Wang, H.-W.;Huang, S.-F.;Wu, A.Y.-J.;Chen, H.-J.;Chen, Y.-C.;Chen, W.-C.;Tseng, C.-H.;Lin, P.-C.;Yang, C.-H.;Hong, P.-L.;Lee, S.S.-J.;Chen, Y.-S.;Liu, Y.-C.;Wang, F.-D.;Chan, Y.-J.;Chang, F.-Y.;Chang, H.-T.;Chen, Y.-C.;Chen, Y.-H.;Cheng, M.-F.;Chi, H.;Chiu, Chiu C.-H.;Ho, M.-W.;Hsieh, S.-M.;Hsueh, P.-R.;Huang, C.-H.;Hung, C.-C.;Hwang, K.-P.;Kao, Kao K.-C.;Ko, W.-C.;Kuo, C.-F.;Lai, C.-H.;Lee, N.-Y.;Lee, S.-J.;Lin, H.-H.;Lin, Y.-T.;Liu, C.-C.;Liu, P.-Y.;Lu, P.-L.;Lu, C.-Y.;Sheng, W.-H.;Tang, H.-J.;Tsai, H.-C.;Wu, T.-S.;Yang, C.-J. |
| 國立成功大學 |
2023 |
Switching to coformulated bictegravir, emtricitabine, and tenofovir alafenamide maintained viral suppression in adults with historical virological failures and K65N/R mutation
|
Tsai, M.-S.;Sun, H.-Y.;Chen, Chen C.-P.;Lee, C.-H.;Lee, C.-Y.;Liu, C.-E.;Tang, H.-J.;Hung, T.-C.;Li, C.-W.;Lee, Y.-T.;Liou, B.-H.;Yang, C.-J.;Hung, C.-C. |
| 國立成功大學 |
2023 |
Inhaled corticosteroid for patients with COVID-19: A systematic review and meta-analysis of randomized controlled trials
|
Hsu, C.-W.;Lee, M.-C.;Hua, Y.-M.;Lai, C.-C.;Tang, H.-J.;Chao, Chao C.-M. |
| 國立成功大學 |
2023 |
Emergence and dissemination of multidrug-resistant Escherichia coli ST8346 coharboring blaNDM-5 and blaOXA-181 in Southern Taiwan, 2017–2021
|
Tsai, C.-H.;Lee, N.-Y.;Chao, Chao C.-M.;Chen, Chen C.-C.;Lai, C.-C.;Ho, C.-H.;Chen, Y.-C.;Chen, P.-Y.;Tang, H.-J.;Chen, H.-J.;Su, B.-A.;Lai, H.-Y.;Chow, J.C.;Chang, T.-H. |
| 臺大學術典藏 |
2022-09-15T05:42:30Z |
Changing epidemiology of shigellosis in Taiwan, 2010-2019: an emerging threat to HIV-infected patients and men who have sex with men
|
Tsai C.-S.; Lin K.-Y.; Liou B.-H.; Chiou C.-S.; Lin Y.-C.; Lee Y.-T.; Yang C.-J.; Tang H.-J.; Liao Y.-S.; Liu C.-E.; Lee C.-H.; Lu P.-L.; Huang S.-H.; CHIEN-CHING HUNG; Ko W.-C.; on behalf of the Taiwan HIV Study Group |
| 臺大學術典藏 |
2022-09-15T05:42:28Z |
Real-world effectiveness of direct-acting antivirals in people living with human immunodeficiency virus and hepatitis C virus genotype 6 infections
|
Sun H.-Y.; Cheng C.-Y.; Lin C.-Y.; Yang C.-J.; Lee N.-Y.; Liou B.-H.; Tang H.-J.; Liu Y.-M.; Lee C.-Y.; Chen T.-C.; Huang Y.-C.; Lee Y.-T.; Tsai M.-J.; Lu P.-L.; Tsai H.-C.; Wang N.-C.; Hung T.-C.; Cheng S.-H.; CHIEN-CHING HUNG |
| 臺大學術典藏 |
2022-09-07T06:39:25Z |
Multicenter study of trimethoprim/sulfamethoxazole-related hepatotoxicity: Incidence and associated factors among HIV-infected patients treated for Pneumocystis jirovecii pneumonia
|
Yang J.-J.; Huang C.-H.; Liu C.-E.; Tang H.-J.; Yang C.-J.; Lee Y.-C.; Lee K.-Y.; Tsai M.-S.; SHU-WEN LIN; Chen Y.-H.; Lu P.-L.; Hung C.-C. |
| 臺大學術典藏 |
2022-06-20T05:55:14Z |
Nationwide surveillance of antimicrobial resistance in invasive isolates of Streptococcus pneumoniae in Taiwan from 2017 to 2019
|
Tsai Y.-T.; Lee Y.-L.; Lu M.-C.; Shao P.-L.; Lu P.-L.; Cheng S.-H.; Ko W.-C.; Lin C.-Y.; Wu T.-S.; Yen M.-Y.; Wang L.-S.; Liu C.-P.; Lee W.-S.; Shi Z.-Y.; Chen Y.-S.; Wang F.-D.; Tseng S.-H.; Lin C.-N.; Chen Y.-H.; WANG-HUEI SHENG; Lee C.-M.; Tang H.-J.; Hsueh P.-R. |
| 國立成功大學 |
2022 |
Economic feasibility assessment of cage aquaculture in offshore wind power generation areas in Changhua County, Taiwan
|
Huang, C.-T.;Afero, F.;Hung, C.-W.;Chen, B.-Y.;Nan, F.-H.;Chiang, W.-S.;Tang, H.-J.;Kang, C.-K. |
| 國立成功大學 |
2022 |
In vitro activity of cefiderocol, cefepime/enmetazobactam, cefepime/zidebactam, eravacycline, omadacycline, and other comparative agents against carbapenem-non-susceptible Pseudomonas aeruginosa and Acinetobacter baumannii isolates associated from bloodst
|
Liu, P.-Y.;Ko, W.-C.;Lee, W.-S.;Lu, P.-L.;Chen, Y.-H.;Cheng, S.-H.;Lu, M.-C.;Lin, C.-Y.;Wu, T.-S.;Yen, M.-Y.;Wang, L.-S.;Liu, C.-P.;Shao, P.-L.;Lee, Y.-L.;Shi, Z.-Y.;Chen, Y.-S.;Wang, F.-D.;Tseng, S.-H.;Lin, C.-N.;Chen, Y.-H.;Sheng, W.-H.;Lee, C.-M.;Tang, H.-J.;Hsueh, P.-R. |
| 國立成功大學 |
2022 |
Real-world effectiveness of direct-acting antivirals in people living with human immunodeficiency virus and hepatitis C virus genotype 6 infections
|
Sun, H.-Y.;Cheng, Cheng C.-Y.;Lin, C.-Y.;Yang, C.-J.;Lee, N.-Y.;Liou, B.-H.;Tang, H.-J.;Liu, Y.-M.;Lee, C.-Y.;Chen, T.-C.;Huang, Y.-C.;Lee, Y.-T.;Tsai, M.-J.;Lu, P.-L.;Tsai, H.-C.;Wang, N.-C.;Hung, T.-C.;Cheng, S.-H.;Hung, C.-C. |
| 國立成功大學 |
2022 |
Clinical efficacy of SGLT2 inhibitors with different SGLT1/SGLT2 selectivity in cardiovascular outcomes among patients with and without heart failure: A systematic review and meta-analysis of randomized trials
|
Lee, M.-C.;Hua, Y.-M.;Yang, C.-T.;Kuo, F.-H.;Chang, W.-T.;Tang, H.-J.;Siong, Toh H.;Lin, Y.-M.;Chen, S.-Y.;Chang, H.-Y.;Liao, C.-T. |
| 國立成功大學 |
2022 |
Experimental and numerical studies on successive failures of two mooring lines of a net cage subjected to currents
|
Tang, H.-J.;Yao, H.-C.;Yang, R.-Y. |
| 國立成功大學 |
2022 |
Nationwide surveillance of antimicrobial resistance in invasive isolates of Streptococcus pneumoniae in Taiwan from 2017 to 2019
|
Tsai, Y.-T.;Lee, Y.-L.;Lu, M.-C.;Shao, P.-L.;Lu, P.-L.;Cheng, S.-H.;Ko, W.-C.;Lin, C.-Y.;Wu, T.-S.;Yen, M.-Y.;Wang, L.-S.;Liu, C.-P.;Lee, W.-S.;Shi, Z.-Y.;Chen, Y.-S.;Wang, F.-D.;Tseng, S.-H.;Lin, C.-N.;Chen, Y.-H.;Sheng, W.-H.;Lee, C.-M.;Tang, H.-J.;Lin, C.-Y.;Chen, Y.-H.;Hsueh, P.-R. |
| 國立成功大學 |
2022 |
NUMERICAL STUDY of AN ALTERNATIVE WAY of EVALUATING the REMAINING VOLUME of A FISH CAGE
|
Tang, H.-J.;Yeh, P.-H.;Yang, R.-Y.;Nan, F.-H. |
| 臺大學術典藏 |
2021-12-01T02:29:11Z |
Echinocandins as alternative treatment for HIV-infected patients with Pneumocystis pneumonia
|
Huang Y.-S.; Liu C.-E.; Lin S.-P.; Lee C.-H.; Yang C.-J.; Lin C.-Y.; Tang H.-J.; Lee Y.-C.; Lin Y.-C.; Lee Y.-T.; Sun H.-Y.; CHIEN-CHING HUNG |
| 臺大學術典藏 |
2021-12-01T02:29:09Z |
Clinical features of acute human immunodeficiency virus infection in Taiwan: A multicenter study
|
Lin T.-Y.; Yang C.-J.; Liu C.-E.; Tang H.-J.; Chen T.-C.; Chen G.-J.; Hung T.-C.; Lin K.-Y.; Cheng C.-Y.; Lee Y.-C.; Lin S.-P.; Tsai M.-S.; Lee Y.-L.; Cheng S.-H.; CHIEN-CHING HUNG; Wang N.-C.; for the Taiwan HIV Study Group |
| 臺大學術典藏 |
2021-09-27T05:32:42Z |
Nationwide surveillance of antimicrobial resistance in invasive isolates of Streptococcus pneumoniae in Taiwan from 2017 to 2019
|
Tsai Y.-T.; Lee Y.-L.; Lu M.-C.; Shao P.-L.; Lu P.-L.; Cheng S.-H.; Ko W.-C.; Lin C.-Y.; Wu T.-S.; Yen M.-Y.; Wang L.-S.; Liu C.-P.; Lee W.-S.; Shi Z.-Y.; Chen Y.-S.; Wang F.-D.; Tseng S.-H.; Lin C.-N.; Chen Y.-H.; WANG-HUEI SHENG; Lee C.-M.; Tang H.-J.; Lin C.-Y.; Chen Y.-H.; Hsueh P.-R. |
| 臺大學術典藏 |
2021-09-27T05:32:41Z |
In vitro activity of cefiderocol, cefepime/enmetazobactam, cefepime/zidebactam, eravacycline, omadacycline, and other comparative agents against carbapenem-non-susceptible Pseudomonas aeruginosa and Acinetobacter baumannii isolates associated from bloodstream infection in Taiwan between 2018–2020
|
Liu P.-Y.; Ko W.-C.; Lee W.-S.; Lu P.-L.; Chen Y.-H.; Cheng S.-H.; Lu M.-C.; Lin C.-Y.; Wu T.-S.; Yen M.-Y.; Wang L.-S.; Liu C.-P.; Shao P.-L.; Lee Y.-L.; Shi Z.-Y.; Chen Y.-S.; Wang F.-D.; Tseng S.-H.; Lin C.-N.; Chen Y.-H.; WANG-HUEI SHENG; Lee C.-M.; Tang H.-J.; Hsueh P.-R. |
| 臺大學術典藏 |
2021-09-27T05:32:37Z |
In-vitro activity of cefiderocol, cefepime/zidebactam, cefepime/enmetazobactam, omadacycline, eravacycline and other comparative agents against carbapenem-nonsusceptible Enterobacterales: results from the Surveillance of Multicenter Antimicrobial Resistance in Taiwan (SMART) in 2017–2020
|
Lee Y.-L.; Ko W.-C.; Lee W.-S.; Lu P.-L.; Chen Y.-H.; Cheng S.-H.; Lu M.-C.; Lin C.-Y.; Wu T.-S.; Yen M.-Y.; Wang L.-S.; Liu C.-P.; Shao P.-L.; Shi Z.-Y.; Chen Y.-S.; Wang F.-D.; Tseng S.-H.; Lin C.-N.; Chen Y.-H.; WANG-HUEI SHENG; Lee C.-M.; Tang H.-J.; Hsueh P.-R. |
| 臺大學術典藏 |
2021-08-27T06:48:54Z |
Evolution of hepatitis A virus seroprevalence among HIV-positive adults in Taiwan
|
Lee Y.-L.; KUAN-YIN LIN; Cheng C.-Y.; Li C.-W.; Yang C.-J.; Tsai M.-S.; Tang H.-J.; Lin T.-Y.; Wang N.-C.; Lee Y.-C.; Lin S.-P.; Huang Y.-S.; Sun H.-Y.; Zhang J.-Y.; Ko W.-C.; Cheng S.-H.; Lee Y.-T.; Liu C.-E.; Hung C.-C.; Taiwan HIV Study Group |
| 臺大學術典藏 |
2021-08-27T06:48:54Z |
Trends and outcomes of late initiation of combination antiretroviral therapy driven by late presentation among HIV-positive Taiwanese patients in the era of treatment scale-up
|
KUAN-YIN LIN; Cheng C.-Y.; Li C.-W.; Yang C.-J.; Tsai M.-S.; Liu C.-E.; Lee Y.-T.; Tang H.-J.; Wang N.-C.; Lin T.-Y.; Lee Y.-C.; Lin S.-P.; Huang Y.-S.; Zhang J.-Y.; Ko W.-C.; Cheng S.-H.; Hung C.-C.; Taiwan HIV Study Group |
| 臺大學術典藏 |
2021-08-27T06:48:50Z |
Clinical features of acute human immunodeficiency virus infection in Taiwan: A multicenter study
|
Lin T.-Y.; Yang C.-J.; Liu C.-E.; Tang H.-J.; Chen T.-C.; Chen G.-J.; Hung T.-C.; KUAN-YIN LIN; Cheng C.-Y.; Lee Y.-C.; Lin S.-P.; Tsai M.-S.; Lee Y.-L.; Cheng S.-H.; Hung C.-C.; Wang N.-C.; for the Taiwan HIV Study Group |
| 臺大學術典藏 |
2021-08-27T06:48:47Z |
Hepatitis B virus seroprevalence among HIV-infected patients receiving combination antiretroviral therapy three decades after universal neonatal hepatitis B immunization program in Taiwan
|
Lin J.-J.; KUAN-YIN LIN; Tang H.-J.; Lin S.-P.; Lee Y.-C.; Liu C.-E.; Huang Y.-S.; Wang N.-C.; Li C.-W.; Ko W.-C.; Yang H.-J.; Lee Y.-T.; Hung C.-C.; Taiwan HIV Study Group |
| 臺大學術典藏 |
2021-08-27T06:48:46Z |
Dual therapy with dolutegravir plus boosted protease inhibitor as maintenance or salvage therapy in highly experienced people living with HIV
|
Lee Y.-L.; KUAN-YIN LIN; Cheng S.-H.; Lu P.-L.; Wang N.-C.; Ho M.-W.; Yang C.-J.; Liou B.-H.; Tang H.-J.; Huang S.-S.; Huang S.-H.; Chen T.-C.; Lin C.-Y.; Lin S.-P.; Lee Y.-T.; Hung C.-C.; Taiwan HIV Study Group |
| 臺大學術典藏 |
2021-08-25T01:53:13Z |
Evolution of hepatitis A virus seroprevalence among HIV-positive adults in Taiwan
|
Lee Y.-L.; KUAN-YIN LIN; Cheng C.-Y.; Li C.-W.; Yang C.-J.; Tsai M.-S.; Tang H.-J.; Lin T.-Y.; Wang N.-C.; Lee Y.-C.; Lin S.-P.; Huang Y.-S.; Sun H.-Y.; Zhang J.-Y.; Ko W.-C.; Cheng S.-H.; Lee Y.-T.; Liu C.-E.; Hung C.-C.; Taiwan HIV Study Group |
| 臺大學術典藏 |
2021-08-25T01:53:13Z |
Trends and outcomes of late initiation of combination antiretroviral therapy driven by late presentation among HIV-positive Taiwanese patients in the era of treatment scale-up
|
KUAN-YIN LIN; Cheng C.-Y.; Li C.-W.; Yang C.-J.; Tsai M.-S.; Liu C.-E.; Lee Y.-T.; Tang H.-J.; Wang N.-C.; Lin T.-Y.; Lee Y.-C.; Lin S.-P.; Huang Y.-S.; Zhang J.-Y.; Ko W.-C.; Cheng S.-H.; Hung C.-C.; Taiwan HIV Study Group |
| 臺大學術典藏 |
2021-08-25T01:53:07Z |
Clinical features of acute human immunodeficiency virus infection in Taiwan: A multicenter study
|
Lin T.-Y.; Yang C.-J.; Liu C.-E.; Tang H.-J.; Chen T.-C.; Chen G.-J.; Hung T.-C.; KUAN-YIN LIN; Cheng C.-Y.; Lee Y.-C.; Lin S.-P.; Tsai M.-S.; Lee Y.-L.; Cheng S.-H.; Hung C.-C.; Wang N.-C.; for the Taiwan HIV Study Group |
| 臺大學術典藏 |
2021-08-25T01:53:03Z |
Hepatitis B virus seroprevalence among HIV-infected patients receiving combination antiretroviral therapy three decades after universal neonatal hepatitis B immunization program in Taiwan
|
Lin J.-J.; KUAN-YIN LIN; Tang H.-J.; Lin S.-P.; Lee Y.-C.; Liu C.-E.; Huang Y.-S.; Wang N.-C.; Li C.-W.; Ko W.-C.; Yang H.-J.; Lee Y.-T.; Hung C.-C.; Taiwan HIV Study Group |
| 臺大學術典藏 |
2021-08-25T01:53:02Z |
Dual therapy with dolutegravir plus boosted protease inhibitor as maintenance or salvage therapy in highly experienced people living with HIV
|
Lee Y.-L.; KUAN-YIN LIN; Cheng S.-H.; Lu P.-L.; Wang N.-C.; Ho M.-W.; Yang C.-J.; Liou B.-H.; Tang H.-J.; Huang S.-S.; Huang S.-H.; Chen T.-C.; Lin C.-Y.; Lin S.-P.; Lee Y.-T.; Hung C.-C.; Taiwan HIV Study Group |
| 臺大學術典藏 |
2021-08-24T08:23:35Z |
Trends and outcomes of late initiation of combination antiretroviral therapy driven by late presentation among HIV-positive Taiwanese patients in the era of treatment scale-up
|
Lin K.-Y.; Cheng C.-Y.; Li C.-W.; Yang C.-J.; Tsai M.-S.; Liu C.-E.; Lee Y.-T.; Tang H.-J.; Wang N.-C.; Lin T.-Y.; Lee Y.-C.; Lin S.-P.; YU-SHAN HUANG; Zhang J.-Y.; Ko W.-C.; Cheng S.-H.; Hung C.-C.; Taiwan HIV Study Group |
| 臺大學術典藏 |
2021-08-24T08:23:34Z |
Changing seroprevalence of hepatitis C virus infection among HIV-positive patients in Taiwan
|
Li C.-W.; Yang C.-J.; Sun H.-Y.; Tsai M.-S.; Lin S.-P.; Lin T.-Y.; Cheng C.-Y.; Lee Y.-C.; YU-SHAN HUANG; Liu C.-E.; Lee Y.-T.; Tang H.-J.; Wang N.-C.; Cheng S.-H.; Ko W.-C.; Hung C.-C. |
| 臺大學術典藏 |
2021-08-24T08:23:34Z |
Evolution of hepatitis A virus seroprevalence among HIV-positive adults in Taiwan
|
Lee Y.-L.; Lin K.-Y.; Cheng C.-Y.; Li C.-W.; Yang C.-J.; Tsai M.-S.; Tang H.-J.; Lin T.-Y.; Wang N.-C.; Lee Y.-C.; Lin S.-P.; YU-SHAN HUANG; Sun H.-Y.; Zhang J.-Y.; Ko W.-C.; Cheng S.-H.; Lee Y.-T.; Liu C.-E.; Hung C.-C.; Taiwan HIV Study Group |
| 臺大學術典藏 |
2021-08-24T08:23:33Z |
Less severe but prolonged course of acute hepatitis a in Human Immunodeficiency Virus (HIV)-infected patients compared with HIV-uninfected patients during an outbreak: A multicenter observational study
|
Lee Y.-L.; Chen G.-J.; Chen N.-Y.; Liou B.-H.; Wang N.-C.; Lee Y.-T.; Yang C.-J.; YU-SHAN HUANG; Tang H.-J.; Huang S.-S.; Lin Y.-C.; Cheng C.-Y.; Lee C.-H.; Chen T.-C.; Wu T.-S.; Liu C.-E.; Lu P.-L.; Hung C.-C.; Lee Y.-C.; Cheng C.-Y.; Cheng S.-H.; YU-SHAN HUANG; Lee Y.-T.; Lin C.-C.; Lin S.-P.; Hsieh C.-Y.; Wang H.-W.; Ho M.-W.; Liu C.-E.; Lee Y.-L.; Lee Y.-C.; Tang H.-J.; Ku H.-C.; Li C.-W.; Lee N.-Y.; Ko W.-C.; Lu P.-L.; Chen Y.-H.; Lin H.-H.; Huang W.-C.; Lee C.-H.; Che T.-C. |
| 臺大學術典藏 |
2021-08-24T08:23:31Z |
Echinocandins as alternative treatment for HIV-infected patients with Pneumocystis pneumonia
|
YU-SHAN HUANG; Liu C.-E.; Lin S.-P.; Lee C.-H.; Yang C.-J.; Lin C.-Y.; Tang H.-J.; Lee Y.-C.; Lin Y.-C.; Lee Y.-T.; Sun H.-Y.; Hung C.-C. |
| 臺大學術典藏 |
2021-08-24T08:23:28Z |
Hepatitis B virus seroprevalence among HIV-infected patients receiving combination antiretroviral therapy three decades after universal neonatal hepatitis B immunization program in Taiwan
|
Lin J.-J.; Lin K.-Y.; Tang H.-J.; Lin S.-P.; Lee Y.-C.; Liu C.-E.; YU-SHAN HUANG; Wang N.-C.; Li C.-W.; Ko W.-C.; Yang H.-J.; Lee Y.-T.; Hung C.-C.; Taiwan HIV Study Group |
| 臺大學術典藏 |
2021-08-24T08:23:27Z |
Efficacy and Safety of Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide as Maintenance Treatment in HIV/HBV-Coinfected Patients
|
YU-SHAN HUANG; Cheng C.-Y.; Liou B.-H.; Lu P.-L.; Cheng S.-H.; Lee Y.-T.; Liu C.-E.; Sun H.-Y.; Yang C.-J.; Tang H.-J.; Lin S.-P.; Ho M.-W.; Huang S.-H.; Tsai H.-C.; Lee C.-H.; Hung C.-C.; Taiwan HIV Study Group |
| 臺大學術典藏 |
2021-08-24T06:05:06Z |
Fusidic acid for the treatment of bone and joint infections caused by meticillin-resistant Staphylococcus aureus
|
Wang J.-L.; Tang H.-J.; Hsieh P.-H.; Chiu F.-Y.; Chen Y.-H.; Chang M.-C.; Huang C.-T.; Liu C.-P.; Lau Y.-J.; Hwang K.-P.; Ko W.-C.; CHEN-TI WANG; Liu C.-Y.; Liu C.-L.; Hsueh P.-R. |
| 臺大學術典藏 |
2021-08-20T07:10:55Z |
Real-World Experience with Coformulated Ledipasvir and Sofosbuvir for HIV-Positive Patients with HCV Genotype 2 Infection: A Multicenter, Retrospective Study
|
Liou B.-H.; HSIN-YUN SUN; Yang C.-J.; Syue L.-S.; Lee Y.-L.; Tang H.-J.; Tsai H.-C.; Lin C.-Y.; Chen T.-C.; Lee C.-Y.; Huang S.-H.; Liu C.-W.; Lu P.-L.; Lin S.-P.; Wang N.-C.; Cheng A.; Ko W.-C.; Cheng S.-H.; Hung C.-C.; the Taiwan HIV Study Group |
| 臺大學術典藏 |
2021-08-20T07:10:55Z |
Efficacy and Safety of Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide as Maintenance Treatment in HIV/HBV-Coinfected Patients
|
Huang Y.-S.; Cheng C.-Y.; Liou B.-H.; Lu P.-L.; Cheng S.-H.; Lee Y.-T.; Liu C.-E.; HSIN-YUN SUN; Yang C.-J.; Tang H.-J.; Lin S.-P.; Ho M.-W.; Huang S.-H.; Tsai H.-C.; Lee C.-H.; Hung C.-C.; Taiwan HIV Study Group |
| 臺大學術典藏 |
2021-08-16T08:36:11Z |
Real-World Experience with Coformulated Ledipasvir and Sofosbuvir for HIV-Positive Patients with HCV Genotype 2 Infection: A Multicenter, Retrospective Study
|
Liou B.-H.; Sun H.-Y.; Yang C.-J.; Syue L.-S.; Lee Y.-L.; Tang H.-J.; Tsai H.-C.; Lin C.-Y.; Chen T.-C.; Lee C.-Y.; Huang S.-H.; Liu C.-W.; Lu P.-L.; Lin S.-P.; Wang N.-C.; ARISTINE CHENG; Ko W.-C.; Cheng S.-H.; Hung C.-C.; the Taiwan HIV Study Group |
| 臺大學術典藏 |
2021-05-18T05:56:58Z |
Antimicrobial-resistant Nocardia isolates, Taiwan, 1998-2009
|
Lai C.-C.; Liu W.-L.; Ko W.-C.; Chen Y.-H.; Tang H.-J.; YU-TSUNG HUANG; Hsueh P.-R. |
| 臺大學術典藏 |
2021-05-18T05:56:51Z |
Clinical and microbiological characteristics of infections caused by various Nocardia species in Taiwan: A multicenter study from 1998 to 2010
|
Liu W.L.; Lai C.C.; Ko W.C.; Chen Y.H.; Tang H.J.; Huang Y.L.; YU-TSUNG HUANG; Hsueh P.R. |
| 臺大學術典藏 |
2021-05-06T08:25:56Z |
National surveillance of antimicrobial susceptibility of bacteremic gram-negative bacteria with emphasis on community-acquired resistant isolates: Report from the 2019 surveillance of multicenter antimicrobial resistance in Taiwan (SMART)
|
Liu P.-Y.;Lee Y.-L.;Lu M.-C.;Pei-Lan Shao;Lu P.-L.;Chen Y.-H.;Cheng S.-H.;Ko W.-C.;Lin C.-Y.;Wu T.-S.;Yen M.-Y.;Wang L.-S.;Liu C.-P.;Lee W.-S.;Chen Y.-S.;Wang F.-D.;Tseng S.-H.;Lin C.-N.;Tang H.-J.;Chen Y.-H.;Sheng W.-H.;Lee C.-M.;Liao M.-H.;Hsueh P.-R.; Liu P.-Y.; Lee Y.-L.; Lu M.-C.; PEI-LAN SHAO; Lu P.-L.; Chen Y.-H.; Cheng S.-H.; Ko W.-C.; Lin C.-Y.; Wu T.-S.; Yen M.-Y.; Wang L.-S.; Liu C.-P.; Lee W.-S.; Chen Y.-S.; Wang F.-D.; Tseng S.-H.; Lin C.-N.; Tang H.-J.; Chen Y.-H.; Sheng W.-H.; Lee C.-M.; Liao M.-H.; Hsueh P.-R. |
| 臺大學術典藏 |
2021-05-06T01:51:42Z |
Species identification and antifungal susceptibility of uncommon blood yeast isolates
|
Li M.-C.; Tang H.-J.; Wu C.-J.; Wang S.-W.; Su S.-L.; Liu W.-L.; Ko W.-C.; YEE-CHUN CHEN |
| 臺大學術典藏 |
2021-05-06T01:25:13Z |
Real-World Experience with Coformulated Ledipasvir and Sofosbuvir for HIV-Positive Patients with HCV Genotype 2 Infection: A Multicenter, Retrospective Study
|
Liou B.-H.; Sun H.-Y.; Yang C.-J.; Syue L.-S.; Lee Y.-L.; Tang H.-J.; Tsai H.-C.; Lin C.-Y.; Chen T.-C.; Lee C.-Y.; Huang S.-H.; Liu C.-W.; Lu P.-L.; Lin S.-P.; Wang N.-C.; Cheng A.; Ko W.-C.; Cheng S.-H.; CHIEN-CHING HUNG; the Taiwan HIV Study Group |
| 臺大學術典藏 |
2021-05-06T01:25:11Z |
Efficacy and Safety of Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide as Maintenance Treatment in HIV/HBV-Coinfected Patients
|
Huang Y.-S.; Cheng C.-Y.; Liou B.-H.; Lu P.-L.; Cheng S.-H.; Lee Y.-T.; Liu C.-E.; Sun H.-Y.; Yang C.-J.; Tang H.-J.; Lin S.-P.; Ho M.-W.; Huang S.-H.; Tsai H.-C.; Lee C.-H.; CHIEN-CHING HUNG; Taiwan HIV Study Group |
| 臺大學術典藏 |
2021-02-26T01:59:51Z |
Carbapenems and piperacillin/tazobactam for the treatment of bacteremia caused by extended-spectrum β-lactamase-producing Proteus mirabilis
|
Tsai H.-Y.;Chen Y.-H.;Tang H.-J.;Huang C.-C.;Liao C.-H.;Chu F.-Y.;Chuang Y.-C.;Wang-Huei Sheng;Ko W.-C.;Hsueh P.-R.; Tsai H.-Y.; Chen Y.-H.; Tang H.-J.; Huang C.-C.; Liao C.-H.; Chu F.-Y.; Chuang Y.-C.; WANG-HUEI SHENG; Ko W.-C.; Hsueh P.-R. |
| 臺大學術典藏 |
2021-02-26T01:59:34Z |
Comparison of serological responses to single-dose azithromycin (2 g) versus benzathine penicillin G in the treatment of early syphilis in HIV-infected patients in an area of low prevalence of macrolide-resistant Treponema pallidum infection
|
Yang C.-J.; Tang H.-J.; Chang S.-Y.; Hsieh S.-M.; Lee K.-Y.; Lee Y.-T.; WANG-HUEI SHENG; Yang S.-P.; Hung C.-C.; Chang S.-C. |
| 臺大學術典藏 |
2021-02-26T01:59:32Z |
Antimicrobial activities of cefoperazone-sulbactam in comparison to cefoperazone against clinical organisms from medical centers in Taiwan
|
Chiang T.-T.;Tang H.-J.;Chiu C.-H.;Chen T.-L.;Ho M.-W.;Lee C.-H.;Wang-Huei Sheng;Yang Y.-S.; Chiang T.-T.; Tang H.-J.; Chiu C.-H.; Chen T.-L.; Ho M.-W.; Lee C.-H.; WANG-HUEI SHENG; Yang Y.-S. |
